-
Mashup Score: 10
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) will hold a one-hour Conversations on Cancer public pane…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2
Click to share this newsletter with your colleagues! OCE PULSE offers a summary of FDA Oncology Center of Excellence (OCE) upcoming public events, educational opportunities, recent oncology product approvals, new publications, and oncology staff profiles. Please hit the “share” button above to send this newsletter to hematology/oncology fellows, faculty, staff, and anyone interested in learning more about what w e do at the OCE! As we come upon the end of 2024, FDA Oncology wishes everyone a restful
Source: content.govdelivery.comCategories: General Medicine News, Oncologists1Tweet-
Just posted! ❄️ December issue of the OCE PULSE monthly newsletter for oncology fellows and professionals. Upcoming meetings, recent drug approvals, publications, training opportunities, and a profile of an FDA Oncology staff member. https://t.co/uc2M2AQniX #OCEProjectSocrates
-
-
Mashup Score: 4
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
Freshly updated for FY24: FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers. https://t.co/aAZHySWnZ7 #OCESciCollab #drugdevelopment #researchfunding https://t.co/zvf2HlsnXD
-
-
Mashup Score: 7FDA grants accelerated approval to zanidatamab-hrii - 1 day(s) ago
On November 20, 2024, the FDA granted accelerated approval to zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals, Inc.) for biliary tract cancer.
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet-
FDA granted accelerated approval to zanidatamab-hrii for previously treated, unresectable or metastatic HER2-positive biliary tract cancer. FDA also approved a companion diagnostic to aid in identifying patients with BTC. https://t.co/qc4GQTk44Y #OCENewsBurst
-
-
Mashup Score: 3Project Facilitate - 1 day(s) ago
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
OCE's Project Facilitate is a single point of contact information center to help oncology healthcare providers or regulatory professionals submit an Expanded Access Request for an individual patient with cancer through FDA's Expanded Access Program. https://t.co/E0R4f0zisR
-
-
Mashup Score: 7Cancer Community Resources - 2 day(s) ago
Information for patients, survivors and families
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
Check out OCE Project Community resources for patients, consumers and caregivers to learn about cancer treatment and participating in a clinical trial. https://t.co/QFteYhxhsA #OCEProjectCommunity
-
-
Mashup Score: 9
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) will hold a one-hour Conversations on Cancer public pane…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
Thank you to today’s Conversations on Cancer panelists and the European Medicines Agency @EMA_News for a thorough examination of how some pediatric cancer patients, their families, oncology professionals and regulators work together to navigate challenges. https://t.co/NCQLFCaLrJ https://t.co/ne4nH1UQCz
-
-
Mashup Score: 2
On Tuesday, December 12, 2023, CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program. Expanded access, sometimes called “compassionate use”, is a potential pathway for a
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
An Overview of FDA’s Project Facilitate Oncology Expanded Access Program —free CE credits! https://t.co/Y0eb1dEnSI #ExpandedAccess #ProjectFacilitate #pharmacy
-
-
Mashup Score: 2
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Oncologists1Tweet-
Join a #ConversationsonCancer virtual event on Nov 19, 2024, hosted by the FDA & the European Medicines Agency @EMA_News, to discuss navigating the challenges of pediatric cancers. #OCEProjectCommunity 🕕 9:30 AM ET | 3:30 PM CEST 💻 Register Now ⤵️ https://t.co/7khUullHB7 https://t.co/UmbYYEXORq
-
-
Mashup Score: 7Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments - 4 day(s) ago
Richard Pazdur, director of FDA’s Oncology Center of Excellence, joined FDA in 1999. Looking back on his 25th anniversary, he draws a line between unpopular …
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
ICYMI: FDA Oncology Center Director Dr. Richard Pazdur spoke recently with the @BioCentury Show about his past 25 with the FDA and his perspectives on a variety of regulatory topics. https://t.co/F7gnOiqhhJ
-
Thank you to today’s Conversations on Cancer panelists and the European Medicines Agency @EMA_News for a thorough examination of how some pediatric cancer patients, their families, oncology professionals and regulators work together to navigate challenges. https://t.co/NCQLFCaLrJ https://t.co/ne4nH1UQCz